‘Three years earlier provides time for intervention,’ the lead researcher says of the early detection test. Mr. Curl covered ...

AbbVie said on Monday its treatment for a group of blood cancers failed to meet the main goal of overall survival in a ...

A programme to evaluate a blood test for early signs of pancreatic cancer has started to recruit volunteers. The Safe-D study ...

AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in ...

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially ...

Researchers at Johns Hopkins University have discovered that cancer can be detected in the bloodstream a full three years ...

NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.

England's National Health Service said Friday it is the first health system in the world to offer a targeted blood cancer ...

Discover the innovation behind the cancer test that identifies tumor markers in blood samples long before symptoms emerge.

Immunotherapy has revolutionized cancer treatment by mobilizing the immune system to attack tumor cells. Major advances, such as immune checkpoint inhibitors (notably against the PD-1 protein), have ...

Researchers detected cancer-linked genetic mutations in blood samples taken over three years before diagnosis. In a ...